JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ozaki, Y.
Right arrow Articles by Kume, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ozaki, Y.
Right arrow Articles by Kume, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 25, Issue of June 23, pp. 15119-15124, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Anti-CD9 Monoclonal Antibody Activates p72 in Human Platelets

Yukio Ozaki , Kaneo Satoh , Kenji Kuroda , Ruomei Qi , Yutaka Yatomi , Shigeru Yanagi , Kiyonao Sada , Hirohei Yamamura , Mutsumasa Yanabu , Shosaku Nomura , Shoji Kume

NNKY 1-19, anti-CD9 monoclonal antibody (MoAb), induced protein tyrosine phosphorylation of 125-, 97-, 75-, 64-, and 40-kDa proteins in human platelets, whereas F(ab`) fragments of NNKY 1-19 did not, suggesting that the stimulation of FcII receptors is required for the induction of protein tyrosine phosphorylation. Tyrosine-phosphorylated proteins of 97 and 125 kDa were associated with aggregation, while NNKY 1-19-induced protein tyrosine phosphorylation was completely inhibited by prostaglandin I (PGI). The activity of p72 was assessed in immunoprecipitation kinase assays to determine at which step the signal transduction pathway leading to protein tyrosine phosphorylation was suspended. NNKY 1-19 induced a rapid and transient increase in the p72-associated tyrosine kinase activity that peaked at 10 s and subsided to the original level 2 min after stimulation. Coinciding with this time course, p60 transiently associated with p72. In platelets preexposed to GRGDS peptides or PGI, NNKY 1-19 also increased the p72-associated tyrosine kinase activity and led to the association of p60 with p72. However, in contrast to the control without any inhibitor, the elevated tyrosine kinase activity and the associated state of the two tyrosine kinases persisted as long as 5 min after stimulation. F(ab`) fragments of NNKY 1-19 induced changes similar to those observed with the effects of GRGDS peptides or PGI treatment on intact IgG NNKY 1-19 stimulation. F(ab`) fragments of another CD9 MoAb, PMA2, had effects on p72essentially similar to those of NNKY 1-19. These findings suggest that the binding of anti-CD9 MoAb to CD9 on the platelet membrane per se induces an increase in the p72-associated tyrosine kinase activity but that FcII receptor-mediated signal(s) is required for the full activation of platelets and the appearance of tyrosine-phosphorylated proteins. The elevated intracellular cAMP level induced by PGI acts at a step distal to the activation of p72 and inhibited the signal transduction pathway leading to protein tyrosine phosphorylation and aggregation. p72activation occurs in the absence of aggregation, but aggregation appears to reduce the elevated p72 activity induced by anti-CD9 MoAb.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
Y. Murayama, J.-i. Miyagawa, K. Oritani, H. Yoshida, K. Yamamoto, O. Kishida, T. Miyazaki, S. Tsutsui, T. Kiyohara, Y. Miyazaki, et al.
CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells
J. Cell Sci., July 1, 2004; 117(15): 3379 - 3388.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. A. Cook, C. M. Longhurst, S. Grgurevich, S. Cholera, J. T. Crossno Jr, and L. K. Jennings
Identification of CD9 extracellular domains important in regulation of CHO cell adhesion to fibronectin and fibronectin pericellular matrix assembly
Blood, December 15, 2002; 100(13): 4502 - 4511.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Kaji, S. Takeshita, K. Miyake, T. Takai, and A. Kudo
Functional Association of CD9 with the Fc{{gamma}} Receptors in Macrophages
J. Immunol., March 1, 2001; 166(5): 3256 - 3265.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Schmid, A. Zurbriggen, U. Gassen, B. Rima, V. ter Meulen, and J. Schneider-Schaulies
Antibodies to CD9, a Tetraspan Transmembrane Protein, Inhibit Canine Distemper Virus-Induced Cell-Cell Fusion but Not Virus-Cell Fusion
J. Virol., August 15, 2000; 74(16): 7554 - 7561.
[Abstract] [Full Text]


Home page
BloodHome page
S. Shallal and J. Kornbluth
CD9 expression enhances the susceptibility of myeloma cell lines to cell-mediated cytolysis
Blood, July 1, 2000; 96(1): 224 - 233.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Klein-Soyer, D. O. Azorsa, J.-P. Cazenave, and F. Lanza
CD9 Participates in Endothelial Cell Migration During In Vitro Wound Repair
Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 360 - 369.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Scherberich, S. Moog, G. Haan-Archipoff, D. O. Azorsa, F. Lanza, and A. Beretz
Tetraspanin CD9 Is Associated With Very Late–Acting Integrins in Human Vascular Smooth Muscle Cells and Modulates Collagen Matrix Reorganization
Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1691 - 1697.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Asazuma, Y. Ozaki, K. Satoh, Y. Yatomi, M. Handa, Y. Fujimura, S. Miura, and S. Kume
Glycoprotein Ib-von Willebrand Factor Interactions Activate Tyrosine Kinases in Human Platelets
Blood, December 15, 1997; 90(12): 4789 - 4798.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Yanabu, Y. Ozaki, S. Nomura, T. Miyake, Y. Miyazaki, H. Kagawa, Y. Yamanaka, N. Asazuma, K. Satoh, S. Kume, et al.
Tyrosine Phosphorylation and p72syk Activation by an Anti-Glycoprotein Ib Monoclonal Antibody
Blood, March 1, 1997; 89(5): 1590 - 1598.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
P. M. Sincock, G. Mayrhofer, and L. K. Ashman
Localization of the Transmembrane 4 Superfamily (TM4SF) Member PETA-3 (CD151) in Normal Human Tissues: Comparison with CD9, CD63, and {alpha}5ss1 Integrin
J. Histochem. Cytochem., January 1, 1997; 45(4): 515 - 526.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Keely and L. V. Parise
The alpha 2beta 1 Integrin Is a Necessary Co-receptor for Collagen-induced Activation of Syk and the Subsequent Phosphorylation of Phospholipase Cgamma 2 in Platelets
J. Biol. Chem., October 25, 1996; 271(43): 26668 - 26676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ichinohe, H. Takayama, Y. Ezumi, S. Yanagi, H. Yamamura, and M. Okuma
Cyclic AMP-insensitive Activation of c-Src and Syk Protein-tyrosine Kinases through Platelet Membrane Glycoprotein VI
J. Biol. Chem., November 24, 1995; 270(47): 28029 - 28036.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ohmori, Y. Yatomi, H. Okamoto, Y. Miura, G. Rile, K. Satoh, and Y. Ozaki
Gi-mediated Cas Tyrosine Phosphorylation in Vascular Endothelial Cells Stimulated with Sphingosine 1-Phosphate. POSSIBLE INVOLVEMENT IN CELL MOTILITY ENHANCEMENT IN COOPERATION WITH Rho-MEDIATED PATHWAYS
J. Biol. Chem., February 9, 2001; 276(7): 5274 - 5280.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.